Michael J. Mauro

Michael J. Mauro is a board-certified hematologist and leader of the Myeloproliferative Neoplasms Program, Leukemia Service at Memorial Sloan Kettering Cancer Center.

Dr Mauro’s clinical expertise is in treating patients with chronic myeloid leukemia (CML) as well as other myeloproliferative disorders, including myelofibrosis, polycythemia and thrombocytosis as well as less common conditions such as eosinophilic and mast cell disorders. His patient care philosophy is to offer in-depth explanation regarding diagnoses and to engage in active partnership with his patients and their referring providers to personalize decision-making and monitoring given the chronic nature of the disorders he treats.

Dr Mauro completed his MD at Dartmouth Medical School, and his Fellowship and Residency at New York-Presbyterian Hospital/Weill Cornell Medical Centre.

Dr Mauro's attendance is supported by Novartis.